Rocket Lab’s selloff looks like the market losing the plot. The company just posted record Q1 revenue of $200.3 million, up 63.5% year over year, while backlog climbed to more than $2.2 billion and management guided to another record quarter. That is not what a fundamentals reset looks like. It looks like a fast-growing space and defense platform getting hit by valuation nerves and Neutron anxiety at the same time.
The cleanest bull argument is that demand is accelerating, not fading. Rocket Lab said it sold more launches in Q1 2026 than in all of 2025, then paired that with its largest launch contract ever: a bulk order for dedicated Neutron and Electron missions from a confidential customer. A company does not build a launch manifest above 70 missions and a backlog above $2.2 billion because customers are pulling back. It does that because its position in the market is getting stronger.
The income statement is starting to reflect that demand. Q1 revenue hit a record $200.3 million, and the broader growth profile still looks powerful with revenue up 38.0% year over year on a trailing basis. Gross margin sits at 36.6%, which matters because it shows Rocket Lab is not just buying growth at any cost. The TickerSpark Score backs up that setup: Growth scores 70, Financial Health scores 84, and Momentum is a perfect 100. For a company still scaling into a much larger opportunity set, those are the numbers that matter more than a headline loss.
The market is also still treating RKLB like a leader, even after the volatility. Shares are up 64.7% year to date, outperforming Industrials by 55.3 percentage points, and the chart remains constructive with the stock above both its 50-day and 200-day moving averages. Consensus estimates are not collapsing either: the analyst mix stands at 13 Buys, 5 Holds, and 1 Sell, with several firms recently reiterating or upgrading bullish views after the Q1 report. When price gets shaky but backlog, estimates, and contract flow keep improving, that usually says more about sentiment than business quality.
The pushback is real, and it starts with valuation. RKLB trades at 104.25 times sales, miles above peers like HEI at 9.39 times sales and VRSK at 7.63 times sales, while profitability is still negative with a -33.2% operating margin and -26.9% net margin. The TickerSpark Score captures that tension too: Valuation is just 20 and Profitability is 35. On top of that, recent insider activity shows 10 sells totaling $14.40 million and no buys, which is never the kind of tape bulls love to see.
Neutron is the other legitimate concern. The January test failure and any further slip in the late-2026 timeline could pressure sentiment because so much of the long-term upside is tied to that vehicle. Still, that risk does not erase what is already working. Rocket Lab is not a pre-revenue promise story anymore; it is a company with $601.8 million in trailing revenue, a rapidly expanding launch and space systems business, and visible contracted demand. The stock is expensive, but expensive and broken are not the same thing.
That keeps us on the bullish side into the next major checkpoint around the expected August earnings report. We would treat this as a momentum-backed growth name where the right question is whether backlog converts and guidance holds up, not whether the business suddenly stopped winning. As long as Rocket Lab keeps posting record revenue, defending that $2.2 billion-plus backlog, and showing Neutron is still on track for late 2026, the bigger trend still points higher.
What would change our mind is straightforward: a meaningful backlog stall, weaker launch demand, or another serious Neutron setback that forces a reset in timing and spending. Short of that, this selloff reads like a backlog disconnect in a stock that the market briefly decided to punish despite the numbers saying the franchise is still getting stronger.
